Skip to main content
letter
. 2020 May 25;53(4):657–659. doi: 10.1016/j.jmii.2020.05.010

Table 1.

Positive rates of (1,3)-β-D-glucan (G), galactomannan (GM), and Candida mannan (Mn) tests in different stages of disease and age groups in severe COVID-19 patients.

Stage of disease No. of patients tested No (%) of patients with positive results in each indicated test
G GM Mn Total (Positive in any of G, GM, MN test)
Early (1–7 days) 15 3 (20.0) 1 (6.7) 0.00 (0) 20.003
Middle (8–14 days) 28 14.28 (4) 7.14 (2) 3.57 (1) 14.284
Late (≥15 days) 138 18.11 (25) 7.97 (11) 1.45 (2) 25.3 (35)

G GM Mn Total
Age (years)
No. of patients
% (No)
% (No)
% (No)
% (No)
20–49 25 24 (6) 0.00 (0) 4.00 (1) 24.00 (6)
50–64 57 12.28 (7) 8.77 (5) 1.75 (1) 21.05 (12)
≥65 99 19.19 (19) 9.09 (9) 1.01 (1) 24.24 (24)